Crossmark

YTHDF1 promotes hepatocellular carcinoma progression via activating PI3K/AKT/mTOR signaling pathway and inducing epithelial-mesenchymal transition

Published Online: 2021-06-04

Published Print: 2021-12

Authors

Luo, Xiangyuan

Cao, Mengdie

Gao, Fan

He, Xingxing http://orcid.org/0000-0003-0001-8473
Funding

Funding for this research was provided by:

National Natural Science Foundation of China (81772969)
License Information

Text and Data Mining valid from 2021-06-04

Version of Record valid from 2021-06-04
More Information

Article History

Received: 14 February 2021

Accepted: 20 May 2021

First Online: 4 June 2021

Declarations

:

: The human tissue acquisition and animal experiment conduction in this study were approved by the Ethics Committee of Tongji Hospital, Huazhong University of Science and Technology. The human tissue acquisition was also obtained informed consent from patients.

: Not applicable.

: The authors declare that they have no competing interests.

Document is current